FiercePharmaAsia—Takeda, WuXi AppTec and Aslan by Angus Liu Friday, March 30, 2018 Takeda weighs a $52 billion Shire bid, WuXi gets approval for a $900M-plus Shanghai IPO, Aslan aims to raise $86 million through an IPO on Nasdaq.
